Enfusion Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

ENFN
Enfusion

Last Price:

10.01

Seasonality Move:

-15.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Enfusion Price Quote

$10.01

-0.12 (-1.18%)

(Updated: November 27, 2024 at 4:25 PM ET)

Enfusion Key Stats

Buy

Enfusion (ENFN) is a Buy

Day range:

$9.83 - $10.18

52-week range:

$7.52 - $10.45

Dividend yield:

P/E ratio:

144.71

P/S ratio:

6.16

P/B ratio:

13.67%

Volume:

537.5K

Avg. volume:

456.9K

1-year change:

2.74%

Market cap:

$956M

Revenue:

$174.5M

EPS:

$0.04

How Much Does Enfusion Make?

How Much Are Enfusion's Sales Annually?
ENFN Revenues are $174.5M
How Much Profit Does Enfusion's Make A Year?
ENFN net income is $6M

Is Enfusion Growing As A Company?

What Is Enfusion's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.15%
What Is Enfusion's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Enfusion Stock Price Performance

Did Enfusion Stock Go Up Last Month?
Enfusion share price went up by 13.06% last month
Did ENFN's Share Price Rise Over The Last Year?
ENFN share price rose by 2.74% over the past 1 year

What Is Enfusion 52-Week High & Low?

What Is Enfusion’s 52-Week High Share Price?
Enfusion has traded as high as $10.45 over the past 52 weeks
What Is Enfusion’s 52-Week Low Share Price?
Enfusion has traded as low as $7.52 over the past 52 weeks

Enfusion Price To Free Cash Flow

Is Enfusion Stock Overvalued?
Enfusion is trading at a price to free cash flow ratio of 57.08
Is Enfusion Stock Undervalued?
Enfusion EV to Free Cash Flow ratio is 44.32
What Is Enfusion’s Price Earnings Growth Ratio?
ENFN PEG ratio is 0.00
Is Enfusion Trading At A Premium To Earnings?
Enfusion EV to EBIT ratio is 139.29

Is It Risky To Buy Enfusion?

How Much Debt Does Enfusion Have?
Total long term debt quarterly is $0
How Much Cash Does Enfusion Have?
Cash and short term investments quarterly total is $48.3M
What Is Enfusion’s Book Value Per Share?
Book value per share is 0.75

Is Enfusion Cash Flow Positive?

What Is ENFN Cash Flow From Operations?
Cash flow from operations (TTM) is $31.6M
What Is Enfusion’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2M
What Is Enfusion’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$13.5M

Enfusion Return On Invested Capital

Is Management Doing A Good Job?
ENFN return on invested capital is 3.97%
What Is Enfusion Return On Assets?
ROA measures how assets are converting to revenues and is 2.88%
What Is ENFN Return On Equity?
ROE is a measure of profitability and is 3.97%

Enfusion Earnings Date & Stock Price

What Is Enfusion's Stock Price Today?
A single share of ENFN can be purchased today for 10.13
What Is Enfusion’s Stock Symbol?
Enfusion trades on the nyse under the ticker symbol: ENFN
When Is Enfusion’s Next Earnings Date?
The next quarterly earnings date for Enfusion is scheduled on March 12, 2025
When Is ENFN's next ex-dividend date?
Enfusion's next ex-dividend date is November 27, 2024
How To Buy Enfusion Stock?
You can buy Enfusion shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Enfusion Competitors

Who Are Enfusion's Competitors?
Below is a list of companies who compete with Enfusion or are related in some way:
- BM Technologies Inc (BMTX)
- Castellum Inc (CTM)
- Cognizant Technology Solutions Corp (CTSH)
- F5 Inc (FFIV)
- Marti Technologies Inc (MRT)

Enfusion Dividend Yield

What Is ENFN Dividend Yield?
Enfusion’s dividend yield currently is 0%
What Is Enfusion’s Payout Ratio?
Enfusion’s payout ratio is 0%
When Did Enfusion Last Pay A Dividend?
The latest dividend pay date is November 27, 2024
What Is Enfusion’s Dividend Per Share?
Enfusion pays a dividend of $0.00 per share

Enfusion Analyst Estimates

	YoY Growth	Past Surprise
EPS:	0%	-11.88%
Revenue:	15.35%	-1.92%

Analyst Recommendations

Buy Recommendations:	2
Hold Recommendations:	3
Sell Recommendations:	0
Price Target:	9.61
Downside from Last Price:	-5.12%

Major Shareholders

How many ENFN shares are owned by institutional investors?
77.3M ENFN shares are owned by institutional investors
How many ENFN shares are owned by insiders?
3.6M ENFN shares are owned by insiders